The FDA finalizes graphic cigarette warning labels

What the rule actually requires

In March 2020 the FDA finalized a rule called "Required Warnings for Cigarette Packages and Advertisements." It set 11 new health warnings for cigarettes. Each one pairs a short line of text with a color photograph showing a health consequence of smoking.

The rule is specific about size. On a cigarette pack, the warning must fill at least the top 50% of the front and rear panels. On cartons, it must fill at least the left 50% of those panels. In print and digital advertising, the warning must take up at least 20% of the ad, at the top.

Manufacturers must also rotate the 11 warnings quarterly and file a plan with FDA showing how they will do it.

The rule was published on 18 March 2020 at 85 FR 15638, with an effective date of 18 June 2021.

Why FDA chose these particular warnings

The Surgeon General's warnings then on packs date from 1984. They are small, text-only, and easy to stop noticing. FDA said the new set was meant to convey "some of the lesser-known, but serious health risks of smoking."

That aim shows in the list. The 11 statements written into the rule cover harm to children from tobacco smoke, fatal lung disease in nonsmokers, type 2 diabetes, reduced blood flow to the limbs that can require amputation, cataracts, bladder cancer, erectile dysfunction, head and neck cancer, heart disease and stroke, stunted fetal growth, and COPD.

Only two of the eleven name a cancer directly. That was deliberate: FDA was targeting risks people did not already associate with smoking.

The rule is not in force

This is the part most summaries get wrong, so it is worth setting out in order.

On 7 December 2022, the U.S. District Court for the Eastern District of Texas vacated the rule in R.J. Reynolds Tobacco Co. v. FDA.

On 21 March 2024, the Fifth Circuit Court of Appeals reversed that decision. It held that FDA's rule is consistent with the First Amendment and sent the case back for the remaining claims.

On 14 January 2025, the district court issued a preliminary injunction and postponed the rule's effective date until final judgment. FDA is appealing.

On 29 August 2025, a second court — the U.S. District Court for the Southern District of Georgia — vacated and set aside the rule in Philip Morris USA Inc. v. FDA.

FDA's own status page says litigation remains pending and that two district courts have issued orders preventing the agency from enforcing the rule. The photographs are not on packs.

What smoking does, in numbers

Tobacco smoke contains more than 7,000 chemicals. NCI reports that at least 250 are known to be harmful and at least 69 can cause cancer.

Lung cancer is the clearest consequence. The counts of about 229,410 new lung and bronchus cancer diagnoses and 124,990 deaths in the United States in 2026 are American Cancer Society projections, listed on SEER's page. Lung cancer causes about one in five cancer deaths, more than any other cancer.

Stage at diagnosis is the reason. Only 24% of lung cancers are found while still confined to the lung. Fifty-one percent are found after spread to distant sites. Five-year relative survival runs 65.5% for localized disease and 10.5% for distant disease. Across all stages it is 29.5% for people diagnosed from 2016 through 2022.

Those are population figures. They pool smokers and never-smokers, every subtype, and every age, and they describe no individual.

Quitting changes the arithmetic

NCI's cessation fact sheet gives the numbers plainly. People who quit before age 40 cut their chance of dying early from a smoking-related disease by about 90%. Quitting between 45 and 54 cuts it by about two-thirds.

Life expectancy follows the same pattern. Quitting between 25 and 34 adds about 10 years. Between 35 and 44, about 9 years. Between 45 and 54, about 6 years. Between 55 and 64, about 4 years. Even people who quit in their 60s had a lower death rate during follow-up than those who kept smoking.

Free help exists. NCI runs Smokefree.gov and a quitline at 1-877-448-7848. Our guide to quitting smoking covers what the evidence says about methods that work.

When to get checked

Two separate questions matter here.

The first is screening. NCI reports that annual low-dose CT scanning cut lung cancer deaths by about 20% to 24% in randomized trials. The benefit was found in people with a heavy smoking history — 20 or more pack-years in one trial, 30 or more in another — roughly aged 50 to 74. A pack-year means one pack a day for one year. If that describes you, ask a clinician whether screening fits. Our page on lung cancer screening explains what the scan involves.

Screening is not free of harm. NCI reports false-positive rates of 23.3% per round in one trial and 10.4% in another, and 1.8% of participants who did not have cancer had an invasive procedure after a positive scan.

The second question is symptoms. NCI's patient summary says to check with a doctor about chest discomfort or pain, a cough that does not go away or worsens over time, trouble breathing, wheezing, blood in coughed-up mucus, hoarseness, loss of appetite, unexplained weight loss, fatigue, trouble swallowing, or swelling in the face or neck veins.

That applies whether or not you ever smoked. NCI notes that some people with no known risk factors develop lung cancer anyway. Our overview of lung cancer covers how the diagnosis is made.

What this does and doesn't change

A labeling rule does not treat anyone. It does not change a diagnosis, a stage, or a treatment plan.

It also has not changed a single pack, because it has never taken effect. Anyone reading "FDA finalizes graphic warnings" as a description of today's cigarette packaging is reading it wrong.

What the record does establish is narrower and still real: an appellate court has held that requiring these images does not violate the First Amendment. Whether they ever appear depends on litigation that is still running. Check FDA's own status page, rather than any news summary including this one, for where it stands now.

Sources

• Federal Register: Tobacco Products — Required Warnings for Cigarette Packages and Advertisements, 85 FR 15638 (govinfo PDF)
• FDA: Cigarette Labeling and Health Warning Requirements
• FDA: Cigarette Health Warning Design Files and Technical Specifications
• NCI PDQ: Lung Cancer Screening (Health Professional Version)
• NCI PDQ: Non-Small Cell Lung Cancer Treatment (Patient Version)
• NCI: Harms of Cigarette Smoking and Health Benefits of Quitting
• NCI SEER Cancer Stat Facts: Lung and Bronchus Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

See an error, old source, or unclear wording? Tell us.